Policy Priorities


Our Priorities


As the voice of the long-term care pharmacy community, SCPC’s policy priorities reflect the unique needs of our members and the patients they serve. LTC pharmacies play an essential role in our health care system—one that is significantly different from and often more complex than that of a typical retail pharmacy. Policy and regulations must reflect these differences.

Our advocacy efforts consider the diverse settings in which LTC pharmacies operate, including skilled nursing facilities, assisted living facilities, hospice, and home.

SCPC’s develops its policy priorities based on the needs of LTC pharmacies around the country and the interests of the patients they serve. Our top priorities include:

image

1


Defining long-term care pharmacies at the federal level

2


Ensuring LTC pharmacies’ role in the expanding home-based services

3


Regulating PBMs and protecting independent pharmacies

Federal Definition of LTC Pharmacy


Defining long-term care pharmacies at the federal level

The Problem: Current federal regulations impose conflicting and confusing obligations on LTC pharmacies. Because the federal government has not formally defined a “long-term care pharmacy,” major discrepancies exist among regulatory bodies such as CMS, EPA and FDA when it comes to the patient care services LTC pharmacies provide.

The Solution: Congress must pass legislation to modernize regulatory oversight of LTC pharmacies and adopt a specific federal definition of “long-term care pharmacy.” A federal definition will allow LTC pharmacies to continue providing high-quality, essential care for LTC patients.

Take Action
image

Resources


Issue Brief

  • Federal Definition of LTC Pharmacy

    View
  • An Overdue Need: The Federal Definition of Long Term Care Pharmacy

    View

Senate Bill Text

  • S. 1574 - To codify a statutory definition for long-term care pharmacies.

    View

House Bill Text

  • H.R. 5632 - To codify a statutory definition for long-term care pharmacies.

    View

Long-Term Care at Home


Ensuring LTC pharmacies’ role in the expanding home-based services and support

The Problem: As our population continues to age, LTC pharmacies provide wraparound clinical and consulting medication management services that keep people who need long-term care in the places they want to be – including their own homes. Public policy and regulations have not kept up with the rise in demand for LTC pharmacies and the crucial services provided to this population.

The Solution: To ensure the best outcomes for LTC patients, SCPC supports the creation of a federal payment platform that appropriately funds LTC pharmacy services, no matter the setting, so patients with long-term care, social, and supportive needs can still live at home in their community if they choose.

image

Resources


Issue Brief

  • Long-Term Care Pharmacy Services are Essential to Effective Expansion of Medicaid-Funded Home and Community-Based Services (HCBS)

    View

SCPC Comment Letter

  • Home and Community Based Access Act Discussion April 26, 2021

    View

Research Reports

  • Expanding Long-Term Care Pharmacy in Home and Community-Based Settings: Understanding and Addressing the Barriers November 2021

    View
  • Understanding the Long-Term Care Needs of the Medicare Population and the Role of Long-Term Care Pharmacies in Addressing this Need July 2021

    View

Fair and Transparent PBM Practices


Regulating PBMs and protecting independent LTC pharmacies

Problem: PBMs engage in predatory business practices including opaque and unjustified fees for pharmacies and market consolidation across the pharmacy, distribution, insurance and healthcare provider sectors. Both practices can delay medication access, increase consumer costs, and force LTC pharmacies and other independent pharmacies to go out of business or sell to the PBM.

Solution: Congress must pass legislation that requires transparency in PBM drug pricing information and provides stronger regulations for CMS to hold PBMs accountable. Congress should also thoroughly investigate PBM business practices for violations of antitrust laws.

image

Resources


Issue Brief

  • Long-Term Care Pharmacies believe patients deserve affordable, cccessible medication; Pharmacy Benefit Managers put profit over care and refuse transparency

    View

SCPC Comment Letters

  • Letter to the FTC - Comments on the Impact of Prescription Benefit Managers’ Business Practices May 25, 2022

    View
  • Letter to CMS - Medicare Program: Contract Year 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefits Programs March 7, 2022

    View
  • Letter to CMS - Advance Notice of Methodological Changes for Calendar Year (CY) 2023 for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies March 4, 2022

    View
  • Other PBM Comment Letters

    View